Highlights The Center’s 2022 Annual Academic Conference Successfully Held in Hong Kong admin December 1, 2022
Highlights Self-Developed and Marketed Class 1 Novel Drug Orelabrutinib Selected as One of China’s 2021 Major Medical Advancements, Included in the 2022 Edition of the CSCO Malignant Hematology Treatment Guidelines admin May 15, 2022
Scientific Progress The Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences has made important progress in human pluripotent stem cell (hPSC) interspecies chimerism technology admin April 15, 2022
